Kyle Kolaja
Affiliations: | Non clinical development Investigative Toxicology | Celgene |
Google:
"Kyle Kolaja"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Belair DG, Sudak K, Connelly K, et al. (2021) Investigation into the Role of ERK in Tyrosine Kinase Inhibitor-Induced Neuropathy. Toxicological Sciences : An Official Journal of the Society of Toxicology |
| Reynolds VL, Butler P, Abernathy MM, et al. (2020) Nonclinical safety assessment of epigenetic modulatory drugs: Current status and industry perspective. Regulatory Toxicology and Pharmacology : Rtp. 117: 104746 |
| Peters MF, Choy AL, Pin C, et al. (2020) Developing in vitro assays to transform gastrointestinal safety assessment: potential for microphysiological systems. Lab On a Chip |
| Belair DG, Lu G, Waller LE, et al. (2020) Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4. Scientific Reports. 10: 2864 |
| Datta K, Kolaja K. (2017) Epigenetics: Druggable targets for anti-cancer therapies Current Opinion in Toxicology. 6: 79-86 |
| Peters MF, Lamore SD, Guo L, et al. (2015) Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line. Cardiovascular Toxicology. 15: 127-39 |
| Drawnel FM, Boccardo S, Prummer M, et al. (2014) Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. Cell Reports. 9: 810-21 |
| Kameoka S, Babiarz J, Kolaja K, et al. (2014) A high-throughput screen for teratogens using human pluripotent stem cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. 137: 76-90 |
| Guo L, Coyle L, Abrams RM, et al. (2013) Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. Toxicological Sciences : An Official Journal of the Society of Toxicology. 136: 581-94 |
| Kolaja K. (2012) Drug discovery: computer model predicts side effects. Nature. 486: 326-7 |